CHINA ISOTOPE & RADIATION CORPORATION China Isotope & Radiation Corporation Stock
Equities
1763
CNE1000031F4
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.28 HKD | -0.58% |
|
+8.90% | -23.05% |
| Apr. 04 | China Isotope & Radiation to Form JV Company | MT |
| Apr. 03 | China Network Group Co., Ltd. Enters into the Investment and Cooperation Agreement with CNNC Hainan Nuclear Power | CI |
| Sales 2021 | 5.14B 711M 5.56B | Sales 2022 | 6.15B 849M 6.65B | Capitalization | 3.78B 522M 4.09B |
|---|---|---|---|---|---|
| Net income 2021 | 336M 46.42M 363M | Net income 2022 | 392M 54.15M 424M | EV / Sales 2021 | 0.74 x |
| Net cash position 2021 | 1.93B 267M 2.09B | Net cash position 2022 | 2.06B 285M 2.23B | EV / Sales 2022 | 0.28 x |
| P/E ratio 2021 |
17.1
x | P/E ratio 2022 |
9.65
x | Employees | 3,105 |
| Yield 2021 |
2.11% | Yield 2022 |
3.73% | Free-Float | 91.21% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -0.58% | ||
| 1 week | +8.90% | ||
| Current month | +1.78% | ||
| 1 month | -11.99% | ||
| 3 months | -11.07% | ||
| 6 months | -14.19% | ||
| Current year | -23.05% |
1 week
9.03
10.52
1 month
9.0311.66
Current year
9.0313.26
1 year
9.0319.24
3 years
9.0332.10
5 years
9.0335.40
10 years
9.0335.40
| Managers | Title | Age | Since |
|---|---|---|---|
Guo Min Fan
BRD | Director/Board Member | 54 | 16-04-30 |
Jin Du
BRD | Director/Board Member | 59 | - |
Hong Chao Xu
BRD | Director/Board Member | 53 | 22-07-28 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Xiu Hong Liu
BRD | Director/Board Member | 57 | 20-12-29 |
Jin Du
BRD | Director/Board Member | 59 | - |
Zhong Lin Liu
BRD | Director/Board Member | 55 | 17-02-21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 10.28 | -0.58% | 190 200 |
| 24-04-24 | 10.34 | +0.19% | 140,000 |
| 24-04-23 | 10.32 | +4.45% | 134,600 |
| 24-04-22 | 9.88 | +6.81% | 892,200 |
| 24-04-19 | 9.25 | -1.60% | 86,000 |
Delayed Quote Hong Kong S.E., April 25, 2024 at 04:09 am EDT
More quotes
China Isotope & Radiation Corporation is a China-based company mainly engaged in research, development, manufacturing and sales of radiopharmaceuticals and radioactive source products. The Company operates mainly through five segments. The Pharmaceuticals segment is mainly engaged in the manufacture and sales of various radiopharmaceuticals for imaging diagnosis and treatment, urea breath test kits and testers, as well as in vitro diagnostic reagents and kits. The Radioactive Source Product segment is mainly engaged in the production and sales of various radioactive source products, and provides related technical services. The Irradiation segment mainly provides irradiation sterilization services and others. The Radiotherapy Equipment and Related Services segment is mainly engaged in the research and development of radiotherapy equipment. The Independent Medical Laboratory Services and Other Business segment mainly provides independent medical laboratory services.
Calendar
2024-08-29
- Q2 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -23.05% | 422M | |
| -1.09% | 12.72B | |
| -12.53% | 7.5B | |
| +0.45% | 5.48B | |
| -1.37% | 4.61B | |
| +3.65% | 4.47B | |
| -52.18% | 3.28B | |
| +11.34% | 2.71B | |
| -19.05% | 2.02B | |
| -11.07% | 1.74B |
- Stock Market
- Equities
- 1763 Stock
